Skip to main content
Top
Published in: Journal of General Internal Medicine 12/2020

01-12-2020 | Back Pain | Concise Research Report

Assessment of Longitudinal Clinical Outcome Measures for Chronic Low Back Pain over 12 Months

Author: John C. Licciardone, DO, MS, MBA

Published in: Journal of General Internal Medicine | Issue 12/2020

Login to get access

Excerpt

The National Institutes of Health Task Force on Research Standards for Chronic Low Back Pain (NIH RTF) identified low back pain intensity, back-related functioning, and quality of life as important clinical outcome domains.1 The RTF recommended that research be conducted on the performance of corresponding measures in these domains, including responsiveness of such measures to changes in low back pain status. The purpose of this study was to assess longitudinal changes in three common measures within these clinical outcome domains over 12 months in patients with chronic low back pain. …
Literature
1.
go back to reference Deyo RA, Dworkin SF, Amtmann D, et al. Report of the NIH Task Force on Research Standards for Chronic Low Back Pain. J Pain 2014;15:569–585.CrossRef Deyo RA, Dworkin SF, Amtmann D, et al. Report of the NIH Task Force on Research Standards for Chronic Low Back Pain. J Pain 2014;15:569–585.CrossRef
2.
go back to reference Licciardone JC, Gatchel RJ, Phillips N, Aryal S. The Pain Registry for Epidemiological, Clinical, and Interventional Studies and Innovation (PRECISION): registry overview and protocol for a propensity score-matched study of opioid prescribing in patients with low back pain. J Pain Res 2018;11:1751–1760.CrossRef Licciardone JC, Gatchel RJ, Phillips N, Aryal S. The Pain Registry for Epidemiological, Clinical, and Interventional Studies and Innovation (PRECISION): registry overview and protocol for a propensity score-matched study of opioid prescribing in patients with low back pain. J Pain Res 2018;11:1751–1760.CrossRef
3.
go back to reference Roland M, Morris R. A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain. Spine 1983;8:141–144.CrossRef Roland M, Morris R. A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain. Spine 1983;8:141–144.CrossRef
4.
go back to reference PROMIS. Adult Profile Instruments. Evanston: Northwestern University; 2015. PROMIS. Adult Profile Instruments. Evanston: Northwestern University; 2015.
5.
go back to reference Licciardone JC, Gatchel RJ, Aryal S. Effects of opioids and nonsteroidal anti-Inflammatory drugs on chronic low back pain and related measures: results from the PRECISION Pain Research Registry. Tex Med 2018;114:e1.PubMed Licciardone JC, Gatchel RJ, Aryal S. Effects of opioids and nonsteroidal anti-Inflammatory drugs on chronic low back pain and related measures: results from the PRECISION Pain Research Registry. Tex Med 2018;114:e1.PubMed
6.
go back to reference Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol 2005;34:215–220.CrossRef Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol 2005;34:215–220.CrossRef
Metadata
Title
Assessment of Longitudinal Clinical Outcome Measures for Chronic Low Back Pain over 12 Months
Author
John C. Licciardone, DO, MS, MBA
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 12/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-05723-3

Other articles of this Issue 12/2020

Journal of General Internal Medicine 12/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.